tirzepatide hfpef 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( At #ACC25, Dr. Milton Packer

Further, GLP-1 RAs were assessed as a class, which may obscure drug specific impact on cancer risk

If its daily, try not to miss doses (if you do, take the next dose at the regular time, dont double up)

Imeglimin Imeglimin is a tetrahydrotriazine that was recently approved to treat type 2 diabetes in Japan (2021) and India (2022) and which has been shown to improve glucose-induced insulin secretion, especially first phase, in clinical trials [14]

Impaired motivation (e.g., in patients with anhedonia) is associated with a reduced quality of life and treatment resistance 85,86

Tirzepatide has now been approved for chronic weight management by the FDA in 2023 following the clinical trials data

Rybelsus is a pill that helps manage blood sugar levels in adults with type 2 diabetes